HBI Deals+Insights / M&A/IPOs
Worldwide Clinical Trials, a US-based contract research organisation (CRO) backed by private equity firm Kohlberg, has agreed to acquire specialised oncology CRO Catalyst Clinical Research from private equity firm QHP Capital.





